Molecular and clinical features of a potential immunotherapy target ELK3 in glioma

Glioma represents the most prevalent malignant primary brain cancer, and its treatment remains a tremendous challenge. Novel and efficient molecular targets are therefore required for improving diagnosis, survival prediction, and treatment outcomes. Additionally, some studies have shown that immunit...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hao, Zhang, Li, Gao, Jin, Wang, Jiajing, Wang, Yihao, Xiao, Dongdong, Chai, Songshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333475/
https://www.ncbi.nlm.nih.gov/pubmed/35905257
http://dx.doi.org/10.1097/MD.0000000000029544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333475/
https://www.ncbi.nlm.nih.gov/pubmed/35905257
http://dx.doi.org/10.1097/MD.0000000000029544

Ejemplares similares